Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Tablet-Based exercise program aims to boost recovery after hip surgery

NCT ID NCT07135843

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This study tests whether a 12-week digital exercise program, with or without personal coaching, can help adults aged 65 and older become more physically active after total hip replacement. Participants will be randomly assigned to one of three groups: the digital program with coaching, the digital program alone, or usual care. Physical activity will be measured using a body-worn sensor before surgery, 6 weeks after, and 6 months after.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
digital exercise program (KOKU app) with or without personal coaching
What this could lead to
If successful, this could provide an effective, low-cost way to improve recovery and physical activity in older adults after hip replacement.
What could go wrong
This is a relatively small, early-stage trial. The digital program may not be more effective than usual care, and results may not apply to all older adults.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 213 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2025

An estimate. Start dates often move.

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥65 years * Coxarthrosis with indication for total hip arthroplasty * Residence within a radius of ≤50 km from Heidelberg * Ability to walk ≥10 m (with/without walking aid) * Access to the internet (Wi-Fi) at home * Written informed consent Exclusion Criteria: * Insufficient German language skills * Insufficient hearing to communicate via (video) telephone * Insufficient vision to recognize study materials * Contralateral coxarthrosis with indication for total hip arthroplasty * Severe medical condition illnesses that compromise physical fitness (heart failure classified as New York Heart Association \[NYHA\] class ≥3, heart valve defects associated with syncope, cardiac arrhythmia with dizziness, chronic obstructive pulmonary disease \[COPD\] with oxygen therapy, cancer with chemotherapy and/or radiation, Parkinson's disease with rollator use \[Hoehn \& Yahr stage ≥4\]) * Living in a nursing home * Planned major medical procedure within the next 6 months with inpatient hospital stay (e.g., further surgery) * Simultaneous participation in another competing study * Cognitive impairment (6-item Cognitive Impairment Test \[6CIT\] score \>7 points)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coxarthrosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Activity osteoarthritis, hip

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of Orthopaedics, Heidelberg University Hospital

    RECRUITING

    Heidelberg, Baden-Wurttemberg, 69118, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.